Evaluation of the application value of mRNA vaccine of monkeypox virus

Abstract. With the advancement of technology in the global business environment, modern medicine has achieved significant milestones in vaccine development, particularly in combating various viral infections. In recent years, the global spread of the monkeypox virus has become a critical issue that the medical community urgently needs to address. This article assesses the potential value of mRNA vaccines in the application against monkeypox virus and provides a comprehensive comparison with traditional vaccines. Compared to traditional vaccines, mRNA vaccines exhibit high potential, safety, and efficacy; the paper thoroughly discusses the mechanism of action of mRNA vaccines, including their steps in the immune response, vaccine preparation, and the mechanism by which mRNA vaccines complete the immune response within infected individuals. Additionally, the article provides a detailed introduction to the synthesis steps and delivery systems of mRNA vaccines. Although the development of mRNA vaccines is still in the early stages and not yet commercially available, their application prospects in cell biology research and disease model construction are broad, and they are expected to become a powerful tool for future cell capture and analysis.